Search Press releases Keywords From To 20 Apr 2023 UCB Showcases Strength and Depth of Neurology Portfolio at 75th American Academy of Neurology (AAN) Annual Meeting Read More 13 Apr 2023 UCB’s Rozanolixizumab and Zilucoplan Phase 3 Generalized Myasthenia Gravis studies published in prestigious The Lancet Neurology Journal Read More 24 Mar 2023 Acquisition of own shares Read More 18 Mar 2023 Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful, Deep and Maintained Response over 48 Weeks Read More 17 Mar 2023 Acquisition of own shares Read More 16 Mar 2023 UCB to Present Eight Bimekizumab Abstracts at AAD 2023 with Results from Studies in Psoriasis, Psoriatic Arthritis and Hidradenitis Suppurativa Read More Pagination First page Previous page Previous … Page 23 Page 24 Page 25 Page 26 Current page 27 Page 28 Page 29 Page 30 Page 31 … Page 27 of 69 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
